Tech Transfer eNews Blog
Industry-Sponsored Research Management sample issue

U Waterloo start-up develops home test kit to monitor heart failure

By Jesse Schwartz
Published: April 4th, 2018

An Ontario-based start-up based on University of Waterloo research is developing a cost-effective way to remotely monitor patients at risk of heart failure.

The technology being commercialized by LeNano Diagnostics allows patients to simply prick their finger and apply the blood sample to a special strip that is then inserted into an electronic reader. Within 20 minutes, the device gives a number indicating the concentration of brain natriuretic peptide (BNP) in the blood. A higher concentration means the patient is at greater risk of heart failure.

“BNP is one of the most important cardiac biomarkers used by health professionals to diagnose heart failure,” says LeNano CEO Charles Lu. “Patients with heart issues normally need to return to hospital or see their doctor for testing. Our kit is simple to use and has accurate and quantitative results, enabling patients to monitor their own levels from home.”

The technology is also Bluetooth-enabled, which allows test results to be automatically sent to a remote care provider. If levels are high, a physician can intervene to advise a patient. This is especially useful to emergency clinicians, for whom fast and accurate assessment is crucial.

The LeNano team will soon begin pilot projects in Canada, the U.S., Europe and Asia.

“Through our new testing system, we can alleviate some of the burden on the healthcare system while at the same time providing a more comforting environment for patients to manage their own health condition,” says Lu. “This is a high-tech, low-cost and effective solution for affordable healthcare.”

Source: Mississauga

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment